Frazier Life Sciences Names Christian Schade as Senior Advisor
Frazier Life Sciences brings on Christian Schade as Senior Advisor to strengthen strategic expertise Frazier Life Sciences (FLS), a well-established investment firm dedicated to advancing innovative biopharmaceutical companies, has announced…
Affinia Therapeutics Secures Health Canada Approval to Launch Phase 1/2 UPBEAT Trial of AFTX-201 in BAG3-Related DCM
Affinia Therapeutics Secures Health Canada Clearance to Launch UPBEAT© Phase 1/2 Trial Evaluating AFTX-201 for BAG3-Related Dilated Cardiomyopathy Affinia Therapeutics, a clinical-stage biotechnology company focused on advancing next-generation gene therapies…
Bridge Dental Group Expands Network with Addition of Foothill Family Dental Group and Peak Dental Specialists
Bridge Dental Group Strengthens Its Growing Network by Adding Foothill Family Dental Group and Peak Dental Specialists Bridge Dental Group has announced a significant expansion of its footprint in the…
Glaukos to Showcase Multiple Scientific Abstracts at the 2026 ASCRS Annual Meeting
Glaukos to Showcase Multiple Scientific Abstracts at the 2026 American Society of Cataract and Refractive Surgery Annual Meeting Glaukos Corporation (NYSE: GKOS), a leading innovator in ophthalmic pharmaceuticals and medical…
Allevion Medical™ Secures 510(k) Clearance for Vantage™, an Innovative Fully Disposable System for Spinal Decompression
Allevion Medical™ Secures 510(k) Clearance for Vantage™, an Innovative Fully Disposable System Designed for Advanced Spinal Decompression Allevion Medical has announced that it has received clearance from the U.S. Food…
Armatus Unveils Breakthrough Data Advancing TVR110 MicroRNA Therapy for Charcot-Marie-Tooth Disease Type 1A
Armatus Reports Promising Breakthrough Data on TVR110, a Vectorized MicroRNA Therapy for Charcot-Marie-Tooth Disease Type 1A Armatus Bio, a late-preclinical biotechnology company focused on developing next-generation vectorized RNA interference (RNAi)…
Clarametyx Biosciences Bolsters Executive Team to Drive Clinical Development Progress
Clarametyx Biosciences Enhances Leadership Team to Advance Clinical Development Initiatives Clarametyx Biosciences, Inc., a clinical-stage biotechnology company focused on developing immune-enabling therapies and vaccines to combat biofilm-driven chronic respiratory diseases,…
Coya Therapeutics Unveils Board Transition Plan, Appoints Mark H. Pavao as Independent Director
Coya Therapeutics Details Upcoming Board Transition, Names Mark H. Pavao as Independent Director Coya Therapeutics, Inc., a clinical-stage biotechnology company focused on developing innovative biologic therapies designed to enhance regulatory…
Curve Biosciences Names Dr. Amit Singal as Chief Medical Officer
Curve Biosciences Announces Appointment of Dr. Amit Singal as Chief Medical Officer Curve Biosciences, a company focused on advancing innovative approaches to whole-body intelligence in healthcare, has announced the appointment…
PureTech Reports Publication of Phase 2b ELEVATE IPF Trial Results in Leading Respiratory Medicine Journal
PureTech Reports Publication of Phase 2b ELEVATE IPF Trial Results in Leading Respiratory Medicine Journal PureTech Health plc, a clinical-stage biotherapeutics company focused on translating cutting-edge science into transformative therapies,…
Glycomine Finishes Patient Enrollment in Global Phase 2b POLAR Trial of GLM101 for PMM2-CDG Treatment
Glycomine Announces Completion of Enrollment in Global Phase 2b POLAR Study Evaluating GLM101 for PMM2-CDG Glycomine, Inc. has announced the successful completion of patient enrollment in its Phase 2b POLAR…
Tenpoint Therapeutics and PHIL Launch YUVEZZI™ Cash Program to Expand Access to Presbyopia Treatment
Tenpoint Therapeutics and PHIL Collaborate to Introduce YUVEZZI™ Direct-to-Patient Cash Program, Improving Access and Affordability for Presbyopia Care Tenpoint Therapeutics, a company focused on advancing innovative treatments in eye care,…